Evaluation of different platforms for the detection of anti-SARS coronavirus-2 antibodies, Thailand - Lerdsamran, Hatairat; Mungaomklang, Anek; Iamsirithaworn, Sopon; Prasertsopon, Jarunee; Prasert, Kriengkrai; Intalapaporn, Poj; Siriyakorn, Nirada; Wiriyarat, Witthawat; Thinpan, Nattakan; Sawadpongpan, Suteema; Sirikhetkon, Somrak; Mongkalangoon, Noparat; et al. (BMC infectious diseases, 2021)
Keywords: Antibodies; Antibody detection; Antigens; Architects; Assaying; Chemiluminescence assay; Coronaviruses; COVID-19; Disease control; ELISA; Enzyme-linked immunosorbent assay; Epidemics; Immunofluorescence; Immunoglobulin G; Immunology; Infections; Informed consent; Laboratories; Microneutralization assay; Performance evaluation; Proteins; Public health; Respiratory diseases; SARS-coronavirus-2; Sensitivity analysis; Seroepidemiology; Serology; Severe acute respiratory syndrome coronavirus 2; Testing; Travellers; Viral antibodies; Viral diseases; Viruses; Thailand; Beijing China; United States--US; China; Antibody detection; Microneutralization assay; SARS-coronavirus-2; Chemiluminescence assay; ELISA